Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,436,287
+$490,471 QoQ
Shares Held
278,274
+9.7% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 403 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. IBRX ranks #73 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in IBRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,436,287 | 278,274 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,945,816 | 253,692 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $579,085 | 292,468 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $548,303 | 222,888 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $542,461 | 205,478 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $553,125 | 183,763 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $336,291 | 131,364 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $488,672 | 131,364 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $827,286 | 130,900 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $618,333 | 115,146 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $605,054 | 120,529 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $199,357 | 117,963 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $331,837 | 119,366 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $101,058 | 55,527 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $227,378 | 44,848 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $228,485 | 45,973 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $156,376 | 42,037 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $180,299 | 32,139 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $188,333 | 30,976 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $301,704 | 30,976 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $177,370 | 12,421 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $223,701 | 9,423 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 NK | — | 17,590 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 NK | — | 3,758 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 NK | — | 4,587 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||